CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- Open-market buys, last 90 days
- $74,198
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$74,198. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-08-19 | FARRELL STEPHEN C Director | Purchase | +1,487 | $3.65 | $5K | 1,487 |
| 2013-08-12 | VON ESCHENBACH ANDREW C. Director | Purchase | +3,000 | $3.69 | $11K | 3,000 |
| 2013-07-01 | VON ESCHENBACH ANDREW C. Director | Grant or award · Option to Purchase Common Shares | +20,000 | 20,000 | ||
| 2013-07-01 | NORDHOFF HENRY L Director | Grant or award · Option to Purchase Common Shares | +20,000 | 20,000 | ||
| 2013-07-01 | LICHTINGER PEDRO Director | Grant or award · Option to Purchase Common Shares | +20,000 | 20,000 | ||
| 2013-07-01 | KINGSLEY ALFRED D Director | Grant or award · Option to Purchase Common Shares | +50,000 | 50,000 | ||
| 2013-07-01 | FARRELL STEPHEN C Director | Grant or award · Option to Purchase Common Shares | +20,000 | 20,000 | ||
| 2013-07-01 | BERGER FRANKLIN M Director | Grant or award · Option to Purchase Common Shares | +20,000 | 20,000 | ||
| 2013-07-01 | BRADSHER NEAL C Director | Grant or award · OPTION TO PURCHASE COMMON SHARES | +20,000 | 20,000 | ||
| 2013-06-04 | KINGSLEY ALFRED D Director | Sale | −320,000 | 6,620,055 | ||
| 2013-06-04 | KINGSLEY ALFRED D Director | Sale · Option to Puchase Common Shares | −80,000 | 0 | ||
| 2013-06-04 | LICHTINGER PEDRO Director | Purchase | +120,000 | 126,250 | ||
| 2013-06-04 | LICHTINGER PEDRO Director | Purchase · Option to Purchase Common Shares | +30,000 | 30,000 | ||
| 2013-06-04 | BROADWOOD PARTNERS LP Director | Purchase | +200,000 | 9,022,220 | ||
| 2013-06-04 | BROADWOOD PARTNERS LP Director | Purchase | +0 | 9,022,220 | ||
| 2013-06-04 | BROADWOOD PARTNERS LP Director | Purchase · Option to Purchase Common Shares | +50,000 | 50,000 | ||
| 2013-03-28 | KINGSLEY ALFRED D Director | Sale | −200,000 | $3.81 | $762K | 7,090,055 |
| 2013-03-28 | BROADWOOD PARTNERS LP Director | Purchase | +200,000 | $3.81 | $762K | 8,822,220 |
| 2013-03-28 | BROADWOOD PARTNERS LP Director | Purchase | +0 | 8,822,220 | ||
| 2013-02-20 | SEGALL JUDITH Vice President & Secretary | Other acquisition · Option to Purchase Common Shares | +50,000 | 50,000 |
Page 23 of 24 · 472 trades